Skip to main content
Signal8

Mayne Pharma Group Limited (MAYNF)

Mayne Pharma Group Limited is an Australian-headquartered specialty pharmaceutical enterprise, engaged in the development, production, and marketing of both patented (branded) and generic drug formulations. Its commercial reach spans Australia, New Zealand, North America (covering the United States and Canada), Europe, and Asia. The company's operations are divided into four main segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. Beyond its own product lines, Mayne Pharma offers sophisticated oral drug delivery technologies and comprehensive contract services—including pharmaceutical development, manufacturing, and analytical testing—to other businesses. Its strategic focus areas for specialty product distribution include dermatology, women's health, and infectious disease treatments. Originally established in 2005, the company operated under the name Halcygen Pharmaceuticals Limited before rebranding to Mayne Pharma Group Limited in November 2010. Its principal office is located in Salisbury South, Australia.

Sector: Medical - Pharmaceuticals

Industry: Medical - Pharmaceuticals

Mayne Pharma Group Limited logo

Mayne Pharma Group Limited

OTC:MAYNFHealthcare
-4.15%$2.19
CLOSED
Mkt Cap$179.75M
EV-
Float75.6M
O/S81.89M
VOL12K sh
$ Vol$26K
RVOL1.68×
Inst Own-
SI0.1%
Net Cash/Sh-
EarningsFeb 24 · in 3mo
Dilution
Mayne Pharma Group Limited logoOTC:MAYNFClosed$2.19-4.15%
Short interest (FINRA)
0.1%
Oct 30 (18d)

Float 75.60M · Polygon free float · Dec 11, 2025

87.7K
Oct 30 (18d)prev 70.9K▲ 23.6%
17.50
Oct 30 (18d)prev 23.14▼ 24.4%
Borrow (IBKR)

The cost to borrow MAYNF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
25.0%
Nov 12 (5d)prev 100.0%▼ 75.0 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis16 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 202687.7K sh
Oct 15, 202670.9K sh
Sep 30, 202680.3K sh
Sep 15, 2026116.9K sh
Aug 31, 2026115.1K sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 12
Latest sessions
DateReported short
Nov 12, 202625.0%
Nov 5, 2026100.0%
Oct 29, 2026100.0%
Oct 28, 2026100.0%
Oct 22, 2026100.0%
21-session median 100.0%mean 91.6%range 12.8–100.0%

130 calendar days requested; 22 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for MAYNF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 87,692 MAYNF shares were sold short (0.12% of a 75.60M-share float, 17.50 days to cover).